Join the discussion below
- Discover why this research study, focusing on diet and quality of life in multiple sclerosis patients, is one of the largest and longest of its kind
- Understand how diet studies differ from drug studies and the importance of randomization in the research process
- Learn about the specific design of the study, its expected outcomes, and how you can participate and contribute to this significant research
Terry Wahls, MD
Welcome to another day of the MS and Neuroimmune Summit. I’m Terry Wahls, your host. And when I talk about my current clinical trial efficacy of diet on the quality of life for the Multiple Sclerosis patients. Now we are actively recruiting for this study. And if we are going to change the state of care, which is my big, hairy, audacious goal, we need these well-designed, randomized, controlled trials. And we are looking for people who are between the ages of 18 and 70 who have relapsing-remitting multiple sclerosis. We will recruit 156 patients. So it will be one of the largest, longest diet studies done in the setting of multiple sclerosis. And we will be comparing three diets. The ketogenic diet and we are using an olive oil-based ketogenic diet because I consider that to be more heart-friendly. We are using the modified paleo diet which basically is the Wahls Elimination diet, and we have the usual diet. Now we have three diets and the control diet is the usual that whatever you are presently eating and it is just so important to have a controlled diet because you need a randomized controlled arm to have the highest quality evidence.
Download Transcript
